Table Of Content
- Executive Summary
- Research Scope & Segmentation
- Research Objectives
- Limitations & Assumptions
- Market Scope & Segmentation
- Currency & Pricing Considered
- Market Opportunity Assessment
- Emerging Regions / Countries
- Emerging Companies
- Emerging Applications / End Use
- Market Trends
- Drivers
- Market Warning Factors
- Latest Macro Economic Indicators
- Geopolitical Impact
- Technology Factors
- Market Assessment
- Porters Five Forces Analysis
- Value Chain Analysis
- Regulatory Framework
- Middle East and Africa
- ESG Trends
- Middle East and Africa Market Analysis
- Introduction
- By Disease Indication
- Introduction
- Disease Indication By Value
- Multiple Sclerosis
- By Value
- Parkinson's Disease
- By Value
- Alzheimer's Disease
- By Value
- Others
- By Value
- Introduction
- By Drug Type
- Introduction
- Drug Type By Value
- Immunomodulator
- By Value
- Vesicular Monoamine Transporter 2 (VMAT2)
- By Value
- Others
- By Value
- Introduction
- By Routes of Administration
- Introduction
- Routes of Administration By Value
- Oral
- By Value
- Intravenous (IV) delivery
- By Value
- Others
- By Value
- Introduction
- UAE
- By Disease Indication
- Introduction
- Disease Indication By Value
- Multiple Sclerosis
- By Value
- Parkinson's Disease
- By Value
- Alzheimer's Disease
- By Value
- Others
- By Value
- Introduction
- By Drug Type
- Introduction
- Drug Type By Value
- Immunomodulator
- By Value
- Vesicular Monoamine Transporter 2 (VMAT2)
- By Value
- Others
- By Value
- Introduction
- By Routes of Administration
- Introduction
- Routes of Administration By Value
- Oral
- By Value
- Intravenous (IV) delivery
- By Value
- Others
- By Value
- Introduction
- By Disease Indication
- Turkey
- Saudi Arabia
- South Africa
- Egypt
- Nigeria
- Rest of MEA
- Competitive Landscape
- Middle East And Africa Neurodegenerative Disease Market Share By Players
- M&A Agreements & Collaboration Analysis
- Market Players Assessment
- Abbvie Inc
- Overview
- Business Information
- Revenue
- ASP
- SWOT Analysis
- Recent Developments
- Amneal Pharmaceuticals Inc.
- Boehringer Ingelheim International GmbHF
- Hoffmann-La Roche
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceuticals Ltd
- UCB SA
- Biogen Inc
- Research Methodology
- Research Data
- Secondary Data
- Major secondary sources
- Key data from secondary sources
- Primary Data
- Key data from primary sources
- Breakdown of primaries
- Secondary And Primary Research
- Key industry insights
- Secondary Data
- Market Size Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Projection
- Research Assumptions
- Assumptions
- Limitations
- Risk Assessment
- Appendix
- Discussion Guide
- Customization Options
- Related Reports
- Disclaimer
Our Clients:
